Company intelligence / Profile preview

iamYiam

London, England, United Kingdom

Ownership: Private
Employees: ~50
Development stage: Other

Overview

iamYiam's syd platform uses AI and population analytics to deliver personalized, science-based wellness and preventive health interventions for employees; early deployment has shown strong engagement and positive initial user outcomes, with ongoing randomized controlled studies in collaboration with NHS and academic partners to validate impact on mental health and wellbeing[1].

Therapeutic areas: PsychiatryOther
Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

NHS North Central London Clinical Commissioning GroupSouthern Health NHS Foundation TrustUniversity of Zurich / Swiss Insurance firmGMTCare (US medical transportation, corporate wellness)Unnamed major EU employee benefits platform[1]

Beyond the preview

Go deeper on iamYiam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iamYiam.

Explore the full profile